Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

Transfusion Technology Products - LOVO instrument – med device CE marked

The Newcastle Upon Tyne Hospitals NHS Foundation Trust · Transparency notice on Find a Tender

Tender information last checkedLast checked 29 Sept 2026, 22:35.

Opportunity overview

Advanced Therapies service for 2x LOVO systems. Direct Award Section 41, Schedule 5 - The justification is an absence of competition and technical reasons. CRCR240163

Classification

No classification was supplied.

Lots

  • Lot 1Value not stated

Documents and notices

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
C340408
Status
complete
Procurement Method
direct
Procurement Method Details
Direct award
Why this procedure was chosen
• The LOVO MED is the only commercially available device with the correct level of CE Marking and the capability to handle all the techniques and processes our department requires. Alternatives on the market, would require the purchase of two different devices to cover the array of processes. • The LOVO system is tailored for larger volume applications, while the Cue system is optimized for small-volume processes. While there are only one or two alternative manufacturers in the field (or world) Fresenius Kabi’s LOVO and Cue machines are specialised in the volumes they treat. • The choice of LOVO and Cue by CGT specialists has been based on Fresenius Kabi’s systems due to the demand on specific criteria, such as volume capacity, automation level, and integration capabilities. • Fresenius Kabi’s Cell and Gene therapy is unique in that it requires advanced biological, genetic, and engineering expertise. It is not a standard piece of equipment that sees many vendors. It involves complex processes such as gene editing, stem cell manipulation, and immune cell reprogramming, which demand specialized equipment and regulatory compliance. • Strict regulations from agencies like the FDA (U.S.), EMA (Europe), and MHRA (UK) govern CGT manufacturing, requiring companies to meet rigorous compliance standards. The regulatory involvement does put off many other manufacturers wishing to develop in this field due to such high focused compliance standards. • The market for CGT is still emerging, with fewer patients receiving these therapies compared to traditional drug treatments. As CGT adoption grows, demand for automated, closed-system collection and processing equipment will maybe increase. This could lead to more competition and innovation, but for now the choice is extremely limited and we are currently the devices of choice in this field.

Legal basis

Id
2023/54
Scheme
UKPGA

Procedure reasons

Entry 1
Id
singleSuppliersTechnicalReasons

Lots and requirements

Entry 1
Id
1
Status
complete

Published documents

Entry 1
Id
conflictOfInterest
Description
Not published
Document Type
conflictOfInterest

Buyer, suppliers and contacts

Organisation 1
Id
GB-PPON-PDCY-5582-YRHQ
Name
The Newcastle Upon Tyne Hospitals NHS Foundation Trust

Roles

buyer

Address

Region
UKC22
Country
GB
Locality
NEWCASTLE UPON TYNE
Postal Code
NE7 7DN
Country Name
United Kingdom
Street Address
Regent Point

Details

Classifications

Entry 1
Id
publicAuthorityCentralGovernment
Scheme
UK_CA_TYPE
Description
Public authority - central government

Identifier

Id
PDCY-5582-YRHQ
Scheme
GB-PPON

Contact

Award information

Award 1
Id
1
Title
Transfusion Technology Products - LOVO instrument – med device CE marked
Status
pending
Above Threshold
Yes
Main Procurement Category
goods

Items

Item 1
Id
1
Related Lot
1

Additional Classifications

Entry 1
Id
33100000
Scheme
CPV
Description
Medical equipments

Value

Amount
188,000
Currency
GBP
Including VAT
225,600

Documents

Entry 1
Id
008323-2025
Format
text/html
Notice Type
UK5
Description
Transparency notice on Find a Tender
Document Type
awardNotice
Published
7 Mar 2025, 11:51

Milestones

Entry 1
Id
1
Type
futureSignatureDate
Status
scheduled
Due
20 Mar 2025, 23:59

Related lots

1

Contract period

Ends
20 Mar 2026, 23:59
Starts
21 Mar 2025, 00:00

Recorded locations

  • Buyer location · NEWCASTLE UPON TYNE · UKC22 · NE7 7DN · United Kingdom

Notice and amendment history

1 published notice version reviewed by ProcuraAxis.

1 VERSION
  1. ocds-h6vhtk-04ea6f-2025-03-07T11:51:11ZTransparency notice on Find a Tender ·